Defunct Company
Total Trials
16
As Lead Sponsor
12
As Collaborator
4
Total Enrollment
2,927
NCT00231153
Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters
Phase: Phase 3
Role: Lead Sponsor
Start: Aug 31, 2005
Completion: Jul 31, 2008
NCT00608959
Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects
Start: May 31, 2008
Completion: Jun 30, 2008
NCT01460667
Efficacy of IV Acetaminophen in Acute Post-Operative Pain Control in Laparoscopic Roux-en-Y Gastric Bypass Surgery (LRYGBP) Patients
Phase: N/A
Role: Collaborator
Start: Oct 31, 2011
Completion: Not specified
NCT01739699
The Efficacy of Intravenous Acetaminophen During Perioperative Neurosurgery Period
Phase: Phase 4
Start: Jan 31, 2012
Completion: Jan 20, 2017
NCT05172817
Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA Patients
Phase: Phase 2/3
Start: Jun 2, 2021
Completion: Oct 30, 2022
NCT05082779
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159
Phase: Phase 1
Start: Oct 26, 2021
Completion: Oct 12, 2022
NCT05624294
Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese Healthy Subjects
Start: Dec 19, 2022
Completion: Mar 28, 2023
NCT05591079
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH
Phase: Phase 2
Start: Feb 10, 2023
Completion: Nov 9, 2023
NCT05896124
CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
Start: Aug 7, 2023
Completion: Jul 31, 2025
NCT05896137
CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
Completion: Nov 30, 2025
NCT06098027
Study of [14C]CS0159 in China Healthy Subjects
Start: Oct 23, 2023
Completion: Nov 2, 2023
NCT06573528
Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects
Start: Sep 3, 2024
Completion: May 21, 2025
NCT06888115
A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury
Start: Mar 13, 2025
Completion: Jun 3, 2025
NCT06485245
Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects
Start: Apr 22, 2025
Completion: Dec 18, 2025
NCT07198386
Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)
Start: Sep 30, 2025
Completion: May 6, 2026